164 related articles for article (PubMed ID: 31096458)
1. Gender differences of in-hospital outcomes in patients undergoing percutaneous coronary intervention in the drug-eluting stent era.
Kim HL; Jang JS; Kim MA; Seo JB; Chung WY; Kim SH; Park SJ; Youn TJ; Yoon MH; Lee JH; Chang K; Jeong MH; Choi RK; Hong MK; Kim HS
Medicine (Baltimore); 2019 May; 98(20):e15557. PubMed ID: 31096458
[TBL] [Abstract][Full Text] [Related]
2. Gender disparity in the use of drug-eluting stents during percutaneous coronary intervention for acute myocardial infarction.
Iyanoye A; Moreyra AE; Swerdel JN; Gandhi SK; Cabrera J; Cosgrove NM; Kostis JB;
Catheter Cardiovasc Interv; 2015 Aug; 86(2):221-8. PubMed ID: 25645156
[TBL] [Abstract][Full Text] [Related]
3. Visit-to-visit variability of systolic blood pressure predicts all-cause mortality in patients received percutaneous coronary intervention with drug-eluting stents.
Seo SM; Chung WB; Choi IJ; Koh YS; Ihm SH; Kim PJ; Chung WS; Seung KB
Heart Vessels; 2018 May; 33(5):489-497. PubMed ID: 29151154
[TBL] [Abstract][Full Text] [Related]
4. Effect of Increasing Stent Length on 3-Year Clinical Outcomes in Women Undergoing Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents: Patient-Level Pooled Analysis of Randomized Trials From the WIN-DES Initiative.
Chandrasekhar J; Baber U; Sartori S; Stefanini GG; Sarin M; Vogel B; Farhan S; Camenzind E; Leon MB; Stone GW; Serruys PW; Wijns W; Steg PG; Weisz G; Chieffo A; Kastrati A; Windecker S; Morice MC; Smits PC; von Birgelen C; Mikhail GW; Itchhaporia D; Mehta L; Kim HS; Valgimigli M; Jeger RV; Kimura T; Galatius S; Kandzari D; Dangas G; Mehran R
JACC Cardiovasc Interv; 2018 Jan; 11(1):53-65. PubMed ID: 29301648
[TBL] [Abstract][Full Text] [Related]
5. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
Onuma Y; Kukreja N; Daemen J; Garcia-Garcia HM; Gonzalo N; Cheng JM; van Twisk PH; van Domburg R; Serruys PW;
JACC Cardiovasc Interv; 2009 Jul; 2(7):603-10. PubMed ID: 19628181
[TBL] [Abstract][Full Text] [Related]
6. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
7. Differential Prognostic Effect Between First- and Second-Generation Drug-Eluting Stents in Coronary Bifurcation Lesions: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
Lee JM; Hahn JY; Kang J; Park KW; Chun WJ; Rha SW; Yu CW; Jeong JO; Jeong MH; Yoon JH; Jang Y; Tahk SJ; Gwon HC; Koo BK; Kim HS
JACC Cardiovasc Interv; 2015 Aug; 8(10):1318-1331. PubMed ID: 26315734
[TBL] [Abstract][Full Text] [Related]
8. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
[TBL] [Abstract][Full Text] [Related]
9. Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents: Analysis From the BIONICS Randomized Trial.
Konigstein M; Ben-Yehuda O; Smits PC; Love MP; Banai S; Perlman GY; Golomb M; Ozan MO; Liu M; Leon MB; Stone GW; Kandzari DE
JACC Cardiovasc Interv; 2018 Dec; 11(24):2467-2476. PubMed ID: 30573057
[TBL] [Abstract][Full Text] [Related]
10. Female gender and mortality after percutaneous coronary intervention: results from a large registry.
Kovacic JC; Mehran R; Karajgikar R; Baber U; Suleman J; Kim MC; Krishnan P; Dangas G; Sharma SK; Kini A
Catheter Cardiovasc Interv; 2012 Oct; 80(4):514-21. PubMed ID: 22045678
[TBL] [Abstract][Full Text] [Related]
11. Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent Registry.
Lee JM; Kang J; Lee E; Hwang D; Rhee TM; Park J; Kim HL; Lee SE; Han JK; Yang HM; Park KW; Na SH; Kang HJ; Koo BK; Kim HS
JACC Cardiovasc Interv; 2016 Oct; 9(20):2097-2109. PubMed ID: 27692820
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.
Wijnbergen I; Tijssen J; van 't Veer M; Michels R; Pijls NH
Catheter Cardiovasc Interv; 2013 Sep; 82(3):379-84. PubMed ID: 23553888
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
[TBL] [Abstract][Full Text] [Related]
14. Impact of peripheral vascular disease on short- and long-term outcomes in patients undergoing non-emergent percutaneous coronary intervention in the drug-eluting stent era.
Midwall S; Swaminathan RV; Charitakis K; Kim LK; Gordin J; Hriljac I; Minutello RM; Bergman G; Wong SC; Feldman DN
J Invasive Cardiol; 2013 Mar; 25(3):132-6. PubMed ID: 23468442
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Impact of Thrombocytopenia in Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
Park S; Ahn JM; Kim TO; Park H; Cho SC; Kang DY; Lee PH; Park DW; Park SJ;
Am J Cardiol; 2020 Nov; 134():55-61. PubMed ID: 32891400
[TBL] [Abstract][Full Text] [Related]
16. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of intravascular ultrasound-guided implantation of bare metal stents versus drug-eluting stents in primary percutaneous coronary intervention.
Cho YK; Hur SH; Park NH; Choi SW; Sohn JH; Cho HO; Park HS; Yoon HJ; Kim H; Nam CW; Kim YN; Kim KB
Korean J Intern Med; 2014 Jan; 29(1):66-75. PubMed ID: 24574835
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes in Diabetic Patients Who Underwent Percutaneous Coronary Intervention during the Plain Old Balloon Angioplasty (POBA)-, Bare Metal Stents (BMS)- and Drug-eluting Stents (DES)-eras from 1984 to 2010.
Naito R; Miyauchi K; Konishi H; Tsuboi S; Ogita M; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Daida H
Intern Med; 2017; 56(1):1-9. PubMed ID: 28049984
[TBL] [Abstract][Full Text] [Related]
19. Comparison of short-term clinical outcomes between Resolute Onyx zotarolimus-eluting stents and everolimus-eluting stent in patients with acute myocardial infarction: Results from the Korea Acute Myocardial infarction Registry (KAMIR).
Kim Y; Oh SS; Jeong MH; Ahn Y; Kim JH; Hong YJ; Sim DS; Kim MC; Kim HS; Yun KH; Oh SK; Kim CJ; Cho MC
Cardiol J; 2019; 26(5):469-476. PubMed ID: 29745969
[TBL] [Abstract][Full Text] [Related]
20. Impact of in-hospital bleeding according to the Bleeding Academic Research Consortium classification on the long-term adverse outcomes in patients undergoing percutaneous coronary intervention.
Yoon YH; Kim YH; Kim SO; Lee JY; Park DW; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2015 Jan; 85(1):63-71. PubMed ID: 24282105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
